The purpose of this clinical guideline is to support staff with the recognition, prevention and treatment of refeeding syndrome in children and young people who have experienced a period of insufficient nutrition.
Coagulation factors are proteins, which in the blood, cause clotting. The factors are manufactured either from human blood (plasma derived) or genetic engineering (recombinant). Advice should be sought from a Consultant Haematologist prior to any decision to prescribe and administer coagulation factors.
This guideline is intended to supplement the resources found in the 'When a Child Dies' (WACD) purple box located in every ward, which gives detailed information on the care of a child after death and, additionally, the ongoing care and attention that the child's family will require (Rationale 1).
The purpose of this guideline is to provide guidance on the care and use of long term Central Venous Access Devices (CVAD) including advice on dealing with any problems encountered. For the purpose of this guideline, devices that are required to remain insitu greater than a month will be considered a long term CVAD.
Note: While this guideline refers to the 'child' throughout, all activities are applicable to young people